Difference between revisions of "Jennifer Petter"
From QueerBio.com
| Line 15: | Line 15: | ||
Transgender Co-founder and Chief Innovation Officer of Arrakis Therapeutics since 2015. Former Vice President, Chemistry at Celgene. Serves on the scientific advisory boards for Cygnal Therapeutics and PIC Therapeutics, and on the boards of directors for OUTBio and Theon Therapeutics. | Transgender Co-founder and Chief Innovation Officer of Arrakis Therapeutics since 2015. Former Vice President, Chemistry at Celgene. Serves on the scientific advisory boards for Cygnal Therapeutics and PIC Therapeutics, and on the boards of directors for OUTBio and Theon Therapeutics. | ||
| + | |||
| + | ==See Also== | ||
| + | |||
| + | * [[LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies]] | ||
==Further Reading/Research== | ==Further Reading/Research== | ||
Latest revision as of 20:44, 19 September 2021
Country
United States
Birth - Death
Occupation
Business
Description
Transgender Co-founder and Chief Innovation Officer of Arrakis Therapeutics since 2015. Former Vice President, Chemistry at Celgene. Serves on the scientific advisory boards for Cygnal Therapeutics and PIC Therapeutics, and on the boards of directors for OUTBio and Theon Therapeutics.
See Also
Further Reading/Research
- https://www.linkedin.com/in/jennifer-petter-39b2a91/
- https://arrakistx.com/author/russp/
- https://timmermanreport.com/2020/09/small-molecules-against-rna-targets-jennifer-petter-on-the-long-run/
- https://endpts.com/meet-jennifer-petter-boston-startup-arrakis-celebrates-a-big-personal-transition-for-top-exec/
